Total Payments
$350,978
2024 Payments
$104,338
Companies
9
Transactions
359
Payment Breakdown by Category
Other$159,562 (45.5%)
Consulting$132,270 (37.7%)
Travel$51,248 (14.6%)
Food & Beverage$7,008 (2.0%)
Education$890.81 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $144,402 | 43 | 41.1% |
| Consulting Fee | $132,270 | 47 | 37.7% |
| Travel and Lodging | $51,248 | 112 | 14.6% |
| Honoraria | $15,160 | 8 | 4.3% |
| Food and Beverage | $7,008 | 110 | 2.0% |
| Education | $890.81 | 39 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Mirum Pharmaceuticals, Inc. | $112,183 | 138 | $0 (2024) |
| Ipsen Biopharmaceuticals, Inc | $89,358 | 42 | $0 (2024) |
| ALBIREO PHARMA, INC. | $76,029 | 43 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $60,334 | 116 | $0 (2024) |
| GENZYME CORPORATION | $7,035 | 3 | $0 (2024) |
| Echosens North America, Inc. | $5,796 | 4 | $0 (2023) |
| Intercept Pharmaceuticals, Inc. | $124.96 | 1 | $0 (2019) |
| Retrophin, Inc. | $114.79 | 9 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $104,338 | 96 | Mirum Pharmaceuticals, Inc. ($57,406) |
| 2023 | $172,418 | 126 | ALBIREO PHARMA, INC. ($54,097) |
| 2022 | $26,629 | 24 | ALBIREO PHARMA, INC. ($21,932) |
| 2021 | $6,922 | 6 | Alexion Pharmaceuticals, Inc. ($4,177) |
| 2020 | $4,203 | 6 | Alexion Pharmaceuticals, Inc. ($4,200) |
| 2019 | $11,819 | 27 | Alexion Pharmaceuticals, Inc. ($11,683) |
| 2018 | $18,453 | 37 | Alexion Pharmaceuticals, Inc. ($18,352) |
| 2017 | $6,195 | 37 | Alexion Pharmaceuticals, Inc. ($6,192) |
All Payment Transactions
359 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2024 | Ipsen Biopharmaceuticals, Inc | Bylvay (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,364.00 | General |
| Category: Gastroenterology | ||||||
| 11/08/2024 | Ipsen Biopharmaceuticals, Inc | Bylvay (Drug) | Travel and Lodging | In-kind items and services | $400.00 | General |
| Category: Gastroenterology | ||||||
| 11/08/2024 | Ipsen Biopharmaceuticals, Inc | Bylvay (Drug) | Food and Beverage | In-kind items and services | $52.00 | General |
| Category: Gastroenterology | ||||||
| 10/22/2024 | Ipsen Biopharmaceuticals, Inc | Bylvay (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,887.00 | General |
| Category: Gastroenterology | ||||||
| 10/22/2024 | Ipsen Biopharmaceuticals, Inc | Bylvay (Drug) | Travel and Lodging | In-kind items and services | $233.16 | General |
| Category: Gastroenterology | ||||||
| 10/22/2024 | Ipsen Biopharmaceuticals, Inc | Bylvay (Drug) | Food and Beverage | In-kind items and services | $109.01 | General |
| Category: Gastroenterology | ||||||
| 09/20/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Consulting Fee | Cash or cash equivalent | $3,080.00 | General |
| Category: Alagille syndrome | ||||||
| 09/20/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Consulting Fee | Cash or cash equivalent | $1,540.00 | General |
| Category: Alagille syndrome | ||||||
| 09/20/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | Cash or cash equivalent | $105.11 | General |
| Category: Alagille syndrome | ||||||
| 09/20/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Travel and Lodging | Cash or cash equivalent | $92.64 | General |
| Category: Alagille syndrome | ||||||
| 09/20/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Travel and Lodging | Cash or cash equivalent | $43.02 | General |
| Category: Alagille syndrome | ||||||
| 09/20/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | Cash or cash equivalent | $18.76 | General |
| Category: Alagille syndrome | ||||||
| 09/20/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | Cash or cash equivalent | $11.35 | General |
| Category: Alagille syndrome | ||||||
| 09/20/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | Cash or cash equivalent | $9.68 | General |
| Category: Alagille syndrome | ||||||
| 09/11/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | Cash or cash equivalent | $149.04 | General |
| Category: Alagille syndrome | ||||||
| 08/23/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Consulting Fee | Cash or cash equivalent | $3,080.00 | General |
| Category: Alagille syndrome | ||||||
| 08/23/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Consulting Fee | Cash or cash equivalent | $2,310.00 | General |
| Category: Alagille syndrome | ||||||
| 08/23/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | In-kind items and services | $42.18 | General |
| Category: Alagille syndrome | ||||||
| 08/06/2024 | Ipsen Biopharmaceuticals, Inc | Bylvay (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,360.00 | General |
| Category: Gastroenterology | ||||||
| 08/03/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | Cash or cash equivalent | $116.46 | General |
| Category: Alagille syndrome | ||||||
| 08/03/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | Cash or cash equivalent | $69.64 | General |
| Category: Alagille syndrome | ||||||
| 08/02/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Consulting Fee | Cash or cash equivalent | $5,600.00 | General |
| Category: Alagille syndrome | ||||||
| 08/02/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Consulting Fee | Cash or cash equivalent | $3,500.00 | General |
| Category: Alagille syndrome | ||||||
| 08/02/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Consulting Fee | Cash or cash equivalent | $770.00 | General |
| Category: Alagille syndrome | ||||||
| 08/02/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Consulting Fee | Cash or cash equivalent | $385.00 | General |
| Category: Alagille syndrome | ||||||
About Dr. Alisha Mavis, MD
Dr. Alisha Mavis, MD is a Pediatrics healthcare provider based in Charlotte, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/01/2008. The National Provider Identifier (NPI) number assigned to this provider is 1053583823.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alisha Mavis, MD has received a total of $350,978 in payments from pharmaceutical and medical device companies, with $104,338 received in 2024. These payments were reported across 359 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($144,402).
Ad
Practice Information
- Specialty Pediatrics
- Other Specialties Pediatric Gastroenterology, Pediatric Transplant Hepatology
- Location Charlotte, NC
- Active Since 04/01/2008
- Last Updated 08/05/2024
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1053583823
Products in Payments
- Bylvay (Drug) $154,213
- Livmarli (Drug) $106,264
- Kanuma (Drug) $10,466
- FibroScan (Device) $5,796
- Strensiq (Drug) $3,689
- XENPOZYME (Biological) $2,145
- KANUMA (Biological) $660.00
- (815) Thiola (Drug) $101.18
- STRENSIQ (Biological) $40.44
- (820) Cholbam (Drug) $16.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Charlotte
Ifeyinwa Osunkwo, Md, MD
Pediatrics — Payments: $385,958
Pediatrics $385,958
Joseph Paolillo, Md, MD
Pediatrics — Payments: $265,203
Pediatrics $265,203
Javier Oesterheld, Md, MD
Pediatrics — Payments: $206,639
Pediatrics $206,639
Charles Mckay, Md, MD
Pediatrics — Payments: $161,959
Pediatrics $161,959
Dedrick Moulton, Md, MD
Pediatrics — Payments: $56,422
Pediatrics $56,422
Paulette Bryant, M.d, M.D
Pediatrics — Payments: $51,612
Pediatrics $51,612